Pharmaceutical News

RSS

GlaxoSmithKline's Votrient will take significant market share away from Pfizer's Sutent by 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.

15 Sep 2009

A.P. Pharma and Merial sign license and development agreement for a long-acting pain management product

A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that it has entered into a license and development agreement with Merial, a world leading animal health company, for a long-acting pain management product.

15 Sep 2009

FluCide more effective than Tamiflu

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Anil Diwan, PhD, President of the Company presented a talk at NanoBusiness 2009 - the 8th annual NanoBusiness Conference in Chicago, IL, on Wednesday, September 9th.

15 Sep 2009

Forest Laboratories places Armour Thyroid medication on back order

Forest Laboratories, Inc., the maker of the widely used hormone therapy drug, Armour® Thyroid, recently announced it has placed the medication on back order. The company said on its website that it does not have enough of the active ingredient, powdered Thyroid gland, in stock to produce the medication.

15 Sep 2009

Wake Pharma to present clinical evidence in the treatment of wounds using Wound-Be-Gone at SAWC

Wake Pharma US announced today that clinical evidence in the treatment of wounds using Wound-Be-Gone® will be presented at the fall Society for Advance Wound Care Conference. The SAWC is being held in Washington, DC from September 16-18, 2009. The clinical evidence and data will be presented through posters on display during the meeting.

15 Sep 2009

Pieris AG and Allergan sign collaboration agreement

Pieris AG today announced that they have entered into a collaboration agreement with Allergan, Inc. (NYSE: AGN) that combines Pieris' proprietary Anticalin technology with Allergan's expertise in drug delivery and ophthalmic drug development with a goal of developing agents for the treatment of serious ocular disorders.

15 Sep 2009

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

Merck Sharp & Dohme Limited (MSD) announced today that ISENTRESS® (raltegravir) has been granted an expanded licence from the European Union Commission (Commission) for use in combination with other antiretroviral (ARV) medicinal products for the treatment of HIV-1 infection in adult patients, including adult patients starting HIV-1 therapy for the first time (treatment-naïve), as well as treatment-experienced adult patients.

15 Sep 2009

Antibiotics sold online without prescriptions, according to MUSC researchers

According to MUSC researchers, antibiotics are widely available for purchase on the Internet without a prescription, despite efforts to control antibiotic-resistant bacteria as a result of misuse of these drugs.

15 Sep 2009

Anti-fungal pill found to be effective for treating oral candidiasis

A once-daily medication option for treating the most common mouth infection in HIV/AIDS patients has shown to be just as effective and safe as taking an anti-fungal pill five times a day, according to a Henry Ford Hospital study.

15 Sep 2009

New operating model for speed delivery of innovative medicines

Eli Lilly and Company (NYSE: LLY) today unveiled a new operating model and announced a series of changes to speed medicines from its pipeline to patients.

15 Sep 2009

Oil-and-water-based nanoemulsion could be more effective for treating burns

Treating second-degree burns with a nanoemulsion lotion sharply curbs bacterial growth and reduces inflammation that otherwise can jeopardize recovery, University of Michigan scientists have shown in initial laboratory studies.

15 Sep 2009

Cell Therapeutics submits Pediatric Investigation Plan to EMEA for pixantrone

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it has submitted a Pediatric Investigation Plan (PIP) to the European Medicines Agency (EMEA) as part of the required filing process for approval of pixantrone for treating relapsed or refractory, aggressive non-Hodgkin's Lymphoma (NHL) in Europe. The PIP outlines how the company proposes to study the drug in children in order to benefit child health.

15 Sep 2009

CFAR to host AIDS Vaccine 2010 conferrence

The Global HIV Vaccine Enterprise (the Enterprise) today announced that the Center for AIDS Research at Emory University (CFAR) in Atlanta, Georgia will serve as Local Host of AIDS Vaccine 2010, the largest and most important global scientific conference focused on AIDS vaccine research.

15 Sep 2009

Environmental Solutions International introduces unique, alcohol-free, moisturizing hand sanitizers

With health officials nationwide already preparing for the upcoming cold and flu season, Environmental Solutions International (ESI) introduces Smart & Silky and Kids Smart & Silky Foaming Hand Sanitizers as another weapon in the illness-prevention arsenal. These unique, alcohol-free, moisturizing hand sanitizers are available at retailers nationwide (visit www.smartandsilky.com for more details).

15 Sep 2009

Mellow Hope completes clinical trial of H1N1 vaccine, receives approval from SFDA

At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly.

15 Sep 2009

AzaSite production increased to combat erythromycin ophthalmic ointment shortage

InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).

15 Sep 2009

IBC offers coverage for H1N1 and seasonal flu vaccines

In an effort to help keep members healthy and flu-free this year, Independence Blue Cross (IBC) will offer coverage for the administration costs of the H1N1 (swine flu) vaccine when it becomes available. In addition, IBC will continue to cover seasonal flu vaccine.

15 Sep 2009

Nebulized interferon-gamma helps minimize transmissibility of TB

A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the lungs and less inflammation, thereby reducing the transmissibility of tuberculosis in the early phase of treatment.

15 Sep 2009

Sigma-Aldrich to distribute BioLife's HypoThermosol and CryoStor biopreservation media products

BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that Sigma-Aldrich(R) will distribute the Company's proprietary HypoThermosol and CryoStor biopreservation media products under the terms of a non-exclusive distribution agreement.

15 Sep 2009

Virtual Pharma Rep - an electronic "go green" revolutionary pharmaceutical sales product

Virtual Pharma Rep™, a new company built by pharmaceutical industry veterans, today announced their launch to market. Virtual Pharma Rep™ delivers a patent pending, virtual sales process that revolutionizes expensive pharmaceutical sales.

14 Sep 2009

Pharmaceutical News

GlaxoSmithKline's Votrient will take significant market share away from Pfizer's Sutent by 2018

A.P. Pharma and Merial sign license and development agreement for a long-acting pain management product

FluCide more effective than Tamiflu

Forest Laboratories places Armour Thyroid medication on back order

Wake Pharma to present clinical evidence in the treatment of wounds using Wound-Be-Gone at SAWC

Pieris AG and Allergan sign collaboration agreement

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

Antibiotics sold online without prescriptions, according to MUSC researchers

Anti-fungal pill found to be effective for treating oral candidiasis

New operating model for speed delivery of innovative medicines

Oil-and-water-based nanoemulsion could be more effective for treating burns

Cell Therapeutics submits Pediatric Investigation Plan to EMEA for pixantrone

CFAR to host AIDS Vaccine 2010 conferrence

Environmental Solutions International introduces unique, alcohol-free, moisturizing hand sanitizers

Mellow Hope completes clinical trial of H1N1 vaccine, receives approval from SFDA

AzaSite production increased to combat erythromycin ophthalmic ointment shortage

IBC offers coverage for H1N1 and seasonal flu vaccines

Nebulized interferon-gamma helps minimize transmissibility of TB

Sigma-Aldrich to distribute BioLife's HypoThermosol and CryoStor biopreservation media products

Virtual Pharma Rep - an electronic "go green" revolutionary pharmaceutical sales product

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News